Cardinal Health to spend $1.2 billion to boost ability to analyze medical data
By Tomi Kilgore
Buying Specialty Networks gives Cardinal Health access to PPS Analytics, which uses AI to analyze data from electronic medical records
Cardinal Health Inc. announced Wednesday an agreement to buy Specialty Networks for $1.2 billion in cash, as the drug distributor and medical products maker looks to enhance its data analytics capabilities.
The company said the acquisition expands its offering in therapeutic areas and increases its data and research opportunities with biopharmaceutical manufacturers.
Cardinal Health's stock (CAH) rose 0.9% in premarket trading, to put it on track to open just below the record closing price of $108.05 on Dec. 13.
"Combining [Specialty Networks'] unique service offerings and advanced technology solutions like PPS Analytics with our distribution partnerships and operations will enhance our value proposition for our specialty GPO [group purchasing organization] members across therapeutic areas," said Debbie Weitzman, chief executive of Cardinal Health Pharmaceutical and Specialty Solutions.
Specialty Networks' PPS Analytics analyzes data, from sources including electronic medical records, imaging and dispensing systems, and uses artificial intelligence to provide insights for providers, researchers, payers and policymakers.
The deal is expected to start adding to Cardinal Health's adjusted earnings per share a year after the closing.
Cardinal's stock has rallied 17.7% over the past three months through Tuesday, while the Health Care Select Sector SPDR ETF (XLV) has climbed 12.9% and the S&P 500 has advanced 17.4%.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
01-31-24 0903ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
The Best REITs to Buy
-
3 Hot Stocks to Buy That Still Look Undervalued
-
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy